Clinical Trial Update: Efficacy and Safety of Selective Serotonin Reuptake Inhibitor (SSRI) in Overactive Bladder Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining the efficacy and safety of a selective serotonin reuptake inhibitor in patients with overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Snippet

Sponsor: Samsung Medical Center | Conditions: Overactive Bladder | Phase 4 | Status: COMPLETED